Completed
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
NCT00780494
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric (Stomach) Cancer, +13 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States